Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025

Concord Medical (NYSE: CCM) filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission on April 29, 2026.

Rhea-AI Summary

Concord Medical (NYSE: CCM) filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission on April 29, 2026.

An electronic copy is available on Concord Medical's investor relations website and on the SEC website; shareholders can request a free hard copy via the investor site.

Argus Apr 29 session

+1.05% close to close Open Argus

Details

News Market Reaction – CCM

On Apr 29, the day this news came out, CCM closed 1.05% above the previous close.

Data tracked by StockTitan Argus for the Apr 29 session.

Key Figures

Fiscal year end: December 31, 2025 Form 20-F year: 2025 Class B shares: 38,287,948 shares +5 more

Fiscal year end

December 31, 2025

Period covered by newly filed Form 20-F

Form 20-F year

2025

Annual report filed with the SEC

Class B shares

38,287,948 shares

Beneficial ownership attributed to Yang Jianyu via Morgancreek

ADS held

466,097 ADS

Indirectly held by Morgancreek; each ADS = 30 Class A shares

Class B shares

7,500,000 shares

Beneficial ownership of director Cheng Zheng via Bluestone

Class A shares

135,000 shares

Direct holdings of director Zhang Liping

Par value

US$0.0001 per share

Par value of Class A ordinary shares

Market cap

$16,715,634

Pre-news market capitalization for CCM

Historical Context

1 past event · Latest: Dec 02

1 event

1. Dec 02

   Shareholder meeting notice

   24h Move

   -3.4%

   Scheduled 2025 AGM and highlighted prior Form 20-F availability.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

form 20-f

1 terms

form 20-f regulatory

"it filed its annual report on Form 20-F for the fiscal year ended"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BEIJING, April 29, 2026 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 (the "Annual Report") with the U.S. Securities and Exchange Commission ("SEC"). An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the Annual Report free of charge upon request. Requests should be submitted to http://ir.ccm.cn. 

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China. For more information, please see http://ir.ccm.cn. 

View original content:https://www.prnewswire.com/news-releases/concord-medical-files-annual-report-on-form-20-f-for-the-fiscal-year-2025-302757128.html

SOURCE Concord Medical Services Holdings Limited

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Concord Medical (CCM) file with the SEC on April 29, 2026?

Concord Medical filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025. According to Concord Medical, the report is available electronically on the company's investor relations website and on the SEC website, and hard copies may be requested free of charge.

Where can investors access Concord Medical's (CCM) 2025 Form 20-F?

Investors can access the 2025 Form 20-F on Concord Medical's investor relations website and the SEC website. According to Concord Medical, an electronic copy is posted at http://ir.ccm.cn and on www.sec.gov, with hard copies available on request.

How can shareholders request a hard copy of Concord Medical's (CCM) 2025 Annual Report?

Shareholders may request a free hard copy of the Annual Report by submitting a request through the investor relations website. According to Concord Medical, requests should be submitted via the company's IR site at http://ir.ccm.cn for delivery.

What period does Concord Medical's (CCM) filed 20-F cover?

The filed Form 20-F covers the fiscal year ended December 31, 2025. According to Concord Medical, the filing on April 29, 2026 is the company's annual report for that fiscal year and is available online for investors.

Does Concord Medical (CCM) provide the Form 20-F on the SEC website?

Yes, the Form 20-F is available on the SEC website as well as the company's investor site. According to Concord Medical, the annual report was filed with the SEC and can be accessed at www.sec.gov and http://ir.ccm.cn.